These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cracking the therapeutic nut in mild cognitive impairment: better nuts and better nutcrackers. Knopman DS Neurology; 2009 May; 72(18):1542-3. PubMed ID: 19176893 [No Abstract] [Full Text] [Related]
7. [Alzheimer drugs for mild cognitive impairment]. Fellgiebel A Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184 [TBL] [Abstract][Full Text] [Related]
8. [Dementia]. Sjöbeck M; Nilsson C Lakartidningen; 2009 May 13-19; 106(20):1369-73. PubMed ID: 19585832 [No Abstract] [Full Text] [Related]
9. [Mild cognitive impairment: a prodromal phase of dementia?]. Jonker C; Comijs HC Tijdschr Gerontol Geriatr; 2007 Jul; 38(3):115-21. PubMed ID: 17642317 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398 [TBL] [Abstract][Full Text] [Related]
11. New therapeutic approaches to cognitive impairment. Schneider LS J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544 [TBL] [Abstract][Full Text] [Related]
12. Mild cognitive impairment: to treat or not to treat. Kirshner HS Curr Neurol Neurosci Rep; 2005 Nov; 5(6):455-7. PubMed ID: 16263056 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693 [TBL] [Abstract][Full Text] [Related]
14. Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia. Krishnan KR; Levy RM; Wagner HR; Chen G; Gersing K; Doraiswamy PM Psychopharmacol Bull; 2001; 35(3):79-88. PubMed ID: 12397880 [TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. Levey A; Lah J; Goldstein F; Steenland K; Bliwise D Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077 [TBL] [Abstract][Full Text] [Related]
16. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment. Small BJ; Gagnon E; Robinson B Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315 [TBL] [Abstract][Full Text] [Related]
18. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. Harry RD; Zakzanis KK Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322 [TBL] [Abstract][Full Text] [Related]
19. Does donepezil improve well-being for dementia due to Alzheimer's disease? Birks J Neuroepidemiology; 2005; 24(3):168-9. PubMed ID: 15677877 [No Abstract] [Full Text] [Related]